FASANO, CANDIDA
 Distribuzione geografica
Continente #
NA - Nord America 570
EU - Europa 143
AS - Asia 92
Totale 805
Nazione #
US - Stati Uniti d'America 560
SG - Singapore 53
IT - Italia 38
SE - Svezia 35
CN - Cina 29
DE - Germania 19
CZ - Repubblica Ceca 13
GB - Regno Unito 13
CA - Canada 10
RU - Federazione Russa 9
VN - Vietnam 7
BE - Belgio 4
LT - Lituania 3
FI - Finlandia 2
FR - Francia 2
IN - India 2
NL - Olanda 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CH - Svizzera 1
IE - Irlanda 1
Totale 805
Città #
Fairfield 98
Woodbridge 60
Ashburn 57
Chandler 49
Seattle 41
Singapore 39
Houston 37
Wilmington 36
Nyköping 33
Cambridge 29
New York 20
Ann Arbor 15
Munich 13
Olomouc 13
Beijing 10
Lawrence 10
London 10
Roxbury 9
Inglewood 8
Dearborn 7
Dong Ket 7
Bari 6
Toronto 6
Nanjing 5
Brussels 4
Cagliari 4
Des Moines 4
Frankfurt am Main 4
Ottawa 4
Quartu Sant'elena 4
Santa Clara 4
Milan 3
Princeton 3
San Giovanni Teatino 3
Sesto San Giovanni 3
Belpasso 2
Bisceglie 2
Cerignola 2
Hebei 2
Jacksonville 2
Jinan 2
Pune 2
Redwood City 2
San Diego 2
Shanghai 2
Brooklyn 1
Dhaka 1
Dublin 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Hefei 1
Hounslow 1
Indiana 1
Jiaxing 1
Los Angeles 1
Marseille 1
Messina 1
Paris 1
Piraino 1
Sarajevo 1
Simi Valley 1
Stimigliano 1
Vaiano 1
Totale 697
Nome #
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 116
Characterization of a rare variant (c.2635-2A>G) of the MSH2 gene in a family with Lynch syndrome 94
null 91
Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3′-end 90
Peptide matching between Epstein–Barr virus and human proteins 85
null 72
FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response 67
Playing on the dark side: Smyd3 acts as a cancer genome keeper in gastrointestinal malignancies 32
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality 27
Identification and Somatic Characterization of the Germline PTEN Promoter Variant rs34149102 in a Family with Gastrointestinal and Breast Tumors 26
Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids 21
Applying the Concept of Peptide Uniqueness to Anti-Polio Vaccination 21
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3 18
Identifying novel SMYD3 interactors on the trail of cancer hallmarks 11
null 11
Tumor Testing and Genetic Analysis to Identify Lynch Syndrome Patients in an Italian Colorectal Cancer Cohort 10
Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review 9
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging 'nonmutational epigenetic reprogramming' cancer hallmark 9
Classic Galactosemia: Clinical and Computational Characterization of a Novel GALT Missense Variant (p.A303D) and a Literature Review 9
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer 8
Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models 7
Coinheritance of germline mutations in APC and MUTYH genes defines the clinical outcome of adenomatous polyposis syndromes 6
c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer 6
Short Linear Motifs in Colorectal Cancer Interactome and Tumorigenesis 5
SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage 5
Identification of a novel germline APC N-terminal pathogenic variant associated with attenuated familial adenomatous polyposis 3
Exploring the Relationship of rs2802292 with Diabetes and NAFLD in a Southern Italian Cohort-Nutrihep Study 3
Colorectal Cancer Chemoprevention: A Dream Coming True? 3
Clinical and Molecular Characterization of SMAD4 Splicing Variants in Patients with Juvenile Polyposis Syndrome 3
In Silico Deciphering of the Potential Impact of Variants of Uncertain Significance in Hereditary Colorectal Cancer Syndromes 3
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance 2
Totale 873
Categoria #
all - tutte 4.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 0 0 0 0 15 19 20 21 10 19 6
2020/2021184 3 7 4 6 17 16 66 19 5 22 7 12
2021/202273 2 5 4 1 1 5 3 5 8 3 11 25
2022/2023134 15 24 10 4 9 20 1 21 25 1 2 2
2023/202495 4 8 0 3 9 31 0 5 1 11 6 17
2024/2025139 30 11 39 13 3 43 0 0 0 0 0 0
Totale 873